SCHEMBL7364753

SCHEMBL7364753

COC(=O)C(CO)NC(c1ccccc1[N+](=O)[O-])S(=O)(=O)c1ccc(OC)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
MMP1 P03956 5/20 0.43
MMP9 P14780 4/20 0.43
MMP13 P45452 4/20 0.43
MMP2 P08253 4/20 0.43
MMP8 P22894 2/20 0.43
CA2 P00918 1/20 0.43
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 4/20 0.41
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
KMT2A Q03164 2/20 0.40
LMNA P02545 2/20 0.40
MAPT P10636 2/20 0.40
PKM P14618 2/20 0.40
GAA P10253 1/20 0.40
PDE4A P27815 3/20 0.40
PDE4B Q07343 3/20 0.40
PDE4C Q08493 3/20 0.40
PDE4D Q08499 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7361148 0.80 ALDH1A1 (0.46) ALDH1A1MMP1MMP9MMP13MMP2
SCHEMBL21952415 0.70 CA1 (0.56) ALDH1A1MMP1MMP9MMP13MMP2
SCHEMBL9375784 0.69 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL9375780 0.69 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL5654237 0.69 MMP1 (0.69) MMP1MMP9MMP13MMP2MMP8
SCHEMBL5639380 0.69 MMP2 (0.57) MMP1MMP9MMP13MMP2MMP8
SCHEMBL28254105 0.68 ALDH1A1 (0.72) ALDH1A1SMN1; SMN2RAB9AKMT2AMAPT
SCHEMBL7346565 0.68 PDE4A (0.47) ALDH1A1MMP1MMP9MMP13MMP2
SCHEMBL29923915 0.68 ALDH1A1 (1.00) ALDH1A1HPGDSMN1; SMN2RAB9AKMT2A
SCHEMBL12788041 0.68 ALDH1A1 (1.00) ALDH1A1HPGDSMN1; SMN2RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147095-A1 2, 3, 4, 5-TETRAHYDRO-1H-[1, 4] BENZODIAZEPINE-3-HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS American Cyanamid Company (US) 2001-10-24 EP disclosed
WO-2000044730-A1 2,3,4,5-TETRAHYDRO-1H-[1,4]BENZODIAZEPINE-3-HYDROXAMIC ACID AS MATRIX METALLOPROTEINASE INHIBITORS AMERICAN CYANAMID COMPANY (US) 2000-08-03 WO disclosed